首页>
外国专利>
USE OF STTIRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF DYSFUNCTIONAL UTERINE HEMORRAGY IN UNION WITH AN ORAL ANTICONCEPTION.
USE OF STTIRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF DYSFUNCTIONAL UTERINE HEMORRAGY IN UNION WITH AN ORAL ANTICONCEPTION.
展开▼
机译：缬草酸雌二醇与Dienogest联合用于联合治疗口服功能障碍性子宫出血的口服抗生素。
展开▼
页面导航
摘要
著录项
相似文献
摘要
A combined polyphasic preparation with a total amount of 28 units of daily doses of estradiol valerate in combination with 17α-cyanomethyl-17β-hydroxystra-4,9-dien-3-one (dienogest), which contains, in this case, a first phase of 2 units of daily doses of estradiol valerate of 3 5 mg, a second phase of 2 groups of units of daily doses, where the first group contains 5 units of daily doses of a combination of 2 mg of estradiol valerate and 2 mg of dienogest, and the second group contains 17 units of daily doses of a combination of 2 mg of estradiol valerate and 3 mg of dienogest, a third phase of 2 units of daily doses with 1 mg of estradiol valerate and another phase of 2 units of daily doses of a pharmaceutically safe placebo, for the use in oral therapy of dysfunctional uterine hemorrhage, whose concept is to understand an increased menstruation hemorrhage, in which the blood loss is greater or same as 80 ml, without organic cause, in conjunction with oral contraception.
展开▼
